Background More than 10 years have elapsed since human papillomavirus (HPV)
vaccination was implemented. We did a systematic review and meta-analysis of the …

Cervical cancer is the fourth most common cancer among women globally. The burden
faced by low-and middle-income countries is significantly greater than high-income …

Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …

Abstract Pre-adolescent girls (9–15 years) have the option of receiving a two dose HPV
vaccine series at either a six month or one year interval to provide protection from HPV 16 …

Background The investigational 9-valent viruslike particle vaccine against human
papillomavirus (HPV) includes the HPV types in the quadrivalent HPV (qHPV) vaccine (6 …

Background Human papillomavirus (HPV) vaccination programmes were first implemented
in several countries worldwide in 2007. We did a systematic review and meta-analysis to …

Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

Human papilloma viruses (HPVs) belong to the Papillomaviridae family and are
epitheliotropic infecting squamous epithelia (skin and mucosae). HPV is estimated to be the …

Skin disease due to viruses may be a primary infection of the epidermis or may arise
secondary to systemic infection. Depending on the virus, the effects may be necrotic damage …

Human papillomaviruses are small DNA viruses with a tropism for squamous epithelia. A
unique aspect of human papillomavirus molecular biology involves dependence on the …